SEI INVESTMENTS CO

Position in RLAY — Relay Therapeutics, Inc.

CIK 350894 OAKS, PA

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$479,537

+$120,044 QoQ

Shares Held

25,630

-29.1% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#153

of 256 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,244,853,717 across 210 Biotechnology names. RLAY ranks #120 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$479,537	25,630	-29.1%	Shares	Sole	2026-08-14
2026-03-31	$359,493	36,130	+41.0%	Shares	Sole	2026-05-13
2025-12-31	$216,829	25,630	0.0%	Shares	Sole	2026-02-13
2025-09-30	$133,788	25,630	0.0%	Shares	Sole	2025-11-13
2025-06-30	$88,679	25,630	0.0%	Shares	Sole	2025-08-14
2025-03-31	$67,150	25,630	+139.7%	Shares	Sole	2025-05-14
2024-03-31	$88,742	10,692	-30.2%	Shares	Sole	2024-05-07
2023-12-31	$168,683	15,321	+18.6%	Shares	Sole	2024-02-14
2023-09-30	$108,622	12,916	-3.0%	Shares	Sole	2023-11-14
2023-06-30	$167,223	13,314	-29.4%	Shares	Sole	2023-08-11
2023-03-31	$310,739	18,867	+20.7%	Shares	Sole	2023-05-12
2022-09-30	$349,643	15,630	+26.8%	Shares	Sole	2022-11-14
2022-06-30	$206,410	12,323	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.